{"id":"https://openalex.org/W2808795368","doi":"https://doi.org/10.2337/db18-2423-pub","title":"Caveolin-1 Was Required for Glargine to Improve Insulin Sensitivity and Activate PI3K/AKT Pathway in Visceral Adipose Tissue of Type 2 Diabetic Mice","display_name":"Caveolin-1 Was Required for Glargine to Improve Insulin Sensitivity and Activate PI3K/AKT Pathway in Visceral Adipose Tissue of Type 2 Diabetic Mice","publication_year":2018,"publication_date":"2018-06-22","ids":{"openalex":"https://openalex.org/W2808795368","doi":"https://doi.org/10.2337/db18-2423-pub","mag":"2808795368"},"language":"en","primary_location":{"id":"doi:10.2337/db18-2423-pub","doi":"https://doi.org/10.2337/db18-2423-pub","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db18-2423-pub","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006597839","display_name":"Hangya Peng","orcid":"https://orcid.org/0000-0002-3634-0686","observed_orcids":["https://orcid.org/0000-0002-3634-0686"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"HANGYA PENG","raw_affiliation_strings":["Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guangzhou, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012399528","display_name":"Haicheng Li","orcid":"https://orcid.org/0000-0002-7268-6967","observed_orcids":["https://orcid.org/0000-0002-7268-6967"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"HAICHENG LI","raw_affiliation_strings":["Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guangzhou, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063945027","display_name":"Shuo Lin","orcid":"https://orcid.org/0000-0002-4860-5864","observed_orcids":["https://orcid.org/0000-0002-4860-5864"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"SHUO LIN","raw_affiliation_strings":["Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guangzhou, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101613824","display_name":"Wen Zeng","orcid":"https://orcid.org/0000-0001-8149-3764","observed_orcids":["https://orcid.org/0000-0001-8149-3764"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"WEN ZENG","raw_affiliation_strings":["Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guangzhou, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074587254","display_name":"Chuwen Lin","orcid":"https://orcid.org/0000-0003-1070-3896","observed_orcids":["https://orcid.org/0000-0003-1070-3896"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"CHUWEN LIN","raw_affiliation_strings":["Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guangzhou, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101767609","display_name":"Keyi Lin","orcid":"https://orcid.org/0000-0002-0659-3842","observed_orcids":["https://orcid.org/0000-0002-0659-3842"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"KEYI LIN","raw_affiliation_strings":["Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guangzhou, China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081066035","display_name":"Longyi Zeng","orcid":"https://orcid.org/0000-0003-4234-6459","observed_orcids":["https://orcid.org/0000-0003-4234-6459"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"LONGYI ZENG","raw_affiliation_strings":["Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guangzhou, China","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":95},"biblio":{"volume":"67","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12793","display_name":"Caveolin-1 and cellular processes","score":0.9452999830245972,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12793","display_name":"Caveolin-1 and cellular processes","score":0.9452999830245972,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.02669999934732914,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.013700000010430813,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/caveolin-1","display_name":"caveolin-1","score":0.9980000257492065},{"id":"https://openalex.org/keywords/glargine","display_name":"glargine","score":0.9810000061988831},{"id":"https://openalex.org/keywords/insulin-sensitivity","display_name":"insulin sensitivity","score":0.7289999723434448},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.9079999923706055},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8560000061988831},{"id":"https://openalex.org/keywords/visceral-adipose-tissue","display_name":"visceral adipose tissue","score":0.9940000176429749},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.8899999856948853},{"id":"https://openalex.org/keywords/insulin-tolerance","display_name":"insulin tolerance","score":0.47200000286102295},{"id":"https://openalex.org/keywords/streptozotocin-induced-diabetes","display_name":"streptozotocin-induced diabetes","score":0.8270000219345093},{"id":"https://openalex.org/keywords/high-fat-high-carbohydrate-diet","display_name":"high-fat high-carbohydrate diet","score":0.7630000114440918},{"id":"https://openalex.org/keywords/lentiviral-shrna-knockdown","display_name":"lentiviral shRNA knockdown","score":0.7839999794960022}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7069194316864014},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6835623979568481},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.6550468802452087},{"id":"https://openalex.org/C2779920387","wikidata":"https://www.wikidata.org/wiki/Q417317","display_name":"Insulin glargine","level":4,"score":0.6474347710609436},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.6360262036323547},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.6332618594169617},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6047523021697998},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5886921882629395},{"id":"https://openalex.org/C171089720","wikidata":"https://www.wikidata.org/wiki/Q193583","display_name":"Adipose tissue","level":2,"score":0.5557124018669128},{"id":"https://openalex.org/C190232843","wikidata":"https://www.wikidata.org/wiki/Q1950808","display_name":"Small hairpin RNA","level":4,"score":0.47389379143714905},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4699820578098297},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.4565443992614746},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4282037615776062},{"id":"https://openalex.org/C2779280383","wikidata":"https://www.wikidata.org/wiki/Q257331","display_name":"Streptozotocin","level":3,"score":0.41570404171943665},{"id":"https://openalex.org/C2780159080","wikidata":"https://www.wikidata.org/wiki/Q1400536","display_name":"Intraperitoneal injection","level":2,"score":0.41331249475479126},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.19763493537902832},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.16732999682426453},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.15675359964370728},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/db18-2423-pub","doi":"https://doi.org/10.2337/db18-2423-pub","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db18-2423-pub","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4200449165","https://openalex.org/W2036943995","https://openalex.org/W2318279843","https://openalex.org/W2096797584","https://openalex.org/W2125201272","https://openalex.org/W2150949849","https://openalex.org/W1984785765","https://openalex.org/W2051676970","https://openalex.org/W4389018726","https://openalex.org/W2354093625"],"abstract_inverted_index":{"Insulin":[0,136],"treatment":[1,34],"improves":[2],"insulin":[3,15,27,120,147,170,173],"sensitivity,":[4],"but":[5],"the":[6,21,184],"underlying":[7],"mechanism":[8],"remains":[9],"unknown.":[10],"Caveolin-1(Cav-1)":[11],"konckout":[12],"mice":[13,41,81],"present":[14],"resistance.Our":[16],"aim":[17],"is":[18,167],"to":[19,63,79,171,182],"investigate":[20],"effect":[22],"of":[23,35,58,77,119,127,135,146],"Cav-1":[24,86,128,166],"depletion":[25],"on":[26],"sensitivity":[28,121,174],"and":[29,122,149,175],"PI3K/AKT":[30,123,150,176],"activation":[31,124,151],"in":[32,100,131],"glargine":[33,71,101,156],"type":[36,65],"2":[37,66],"diabetic":[38],"mice.":[39,69],"C57BL/6J":[40],"were":[42,129],"divided":[43],"into":[44],"five":[45],"groups(n=5":[46],"for":[47,60,82,169],"each":[48],"group).We":[49],"firstly":[50],"used":[51],"high-fat":[52],"high-carbonhydrate":[53],"diet":[54],"with":[55,106,125,139,158],"intraperitoneal":[56],"injection":[57,99,109],"streptozotocin(40mg/kg":[59],"3":[61,83],"days)":[62],"induce":[64],"diabetic(T2DM":[67],"group)":[68,105],"Next,":[70],"was":[72,88],"started":[73],"at":[74],"a":[75,111,116],"dose":[76],"0.4u/day":[78],"T2DM":[80,103,140],"weeks(Insulin":[84],"group).Lastly,":[85],"expression":[87],"silenced":[89],"by":[90,155],"lentiviral-vectored":[91],"short":[92],"hairpin":[93],"RNA":[94],"(shRNA)":[95],"through":[96],"tail":[97],"vein":[98],"treated":[102],"mice(CAV1-shRNA":[104],"scramble":[107],"virus":[108],"as":[110],"negative":[112],"control(Ctrl-shRNA":[113],"group).":[114],"As":[115],"result,":[117],"improvement":[118],"upregulation":[126],"observed":[130],"visceral":[132],"adipose":[133],"tissue":[134],"group":[137,141,160],"compared":[138,157],"(P<0.05).":[142,161],"In":[143],"CAV1-shRNA":[144],"group,impairment":[145],"tolerance":[148],"couldn\u2019t":[152],"be":[153],"improved":[154],"Ctrl-shRNA":[159],"Our":[162],"findings":[163],"suggest":[164],"that":[165],"required":[168],"improve":[172],"activation.":[177],"More":[178],"studies":[179],"are":[180],"needed":[181],"elucidate":[183],"mechanism.":[185],"Disclosure":[186],"H.":[187,190],"Peng:":[188],"None.":[189,192,195,198,201,204,207],"Li:":[191],"S.":[193],"Lin:":[194,200,203],"W.":[196],"Zeng:":[197,206],"C.":[199],"K.":[202],"L.":[205]},"counts_by_year":[{"year":2025,"cited_by_count":2}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2018-06-29T00:00:00"}